[CYCC] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
11-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 21.77%
YoY- -41.29%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 31 16 373 0 0 0 0 -
PBT -6,093 -6,699 -6,034 -7,124 -9,000 -6,110 -5,559 6.28%
Tax -822 -602 -586 -1,320 -1,581 -1,014 -984 -11.27%
NP -5,271 -6,097 -5,448 -5,804 -7,419 -5,096 -4,575 9.87%
Tax Rate - - - - - - - -
Total Cost 5,302 6,113 5,821 5,804 7,419 5,096 4,575 10.30%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -17,003.23 -38,106.25 -1,460.59 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -6.17 -7.23 -6.51 -6.94 -8.87 -0.41 -0.45 470.13%
EPS Diluted -6.17 -7.23 -6.51 -6.94 -8.87 -0.41 -0.45 470.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.